Skip to main content
RKLBFYI

Intelligence Hub

Market analytics and operational performance indicators

Last Updated: 8 minutes ago
Back to Filings
FORM 144
AI

144 - March 2, 2026

Filed March 2, 2026
·
0002001011-26-000017

Officer Adam Spice files Form 144 to sell 62,744 shares for RSU tax coverage.

Brief

Rocket Lab officer Adam C. Spice filed Form 144 on March 2, 2026, notifying the proposed sale of 62,744 common shares valued at $4.37 million. The sale covers tax obligations from the vesting of 114,845 restricted stock units on March 1, 2026. This is routine insider activity following a larger sale by Spice in January.

Detailed Brief

Form 144 is a notice of proposed sale of restricted securities by an affiliate under Rule 144. Here, Rocket Lab Corp officer Adam C. Spice intends to sell 62,744 shares of common stock through Morgan Stanley on or around March 2, 2026, with an aggregate market value of $4,366,347.18 based on the filing date, against 567,445,449 shares outstanding. The shares stem from compensation via vesting of 114,845 restricted stock units acquired from the issuer on March 1, 2026. The filing explicitly notes the sale includes amounts to satisfy tax withholding on the vested equity award settlement. Spice previously sold 1,365,665 shares on January 5, 2026, for gross proceeds of $103,112,350.76. Spice represents no knowledge of undisclosed material adverse information about Rocket Lab.

Key Telemetry

  • Adam C. Spice (Officer) to sell 62,744 common shares (~$4.37M) on 03/02/2026.
  • Sale covers taxes on vesting of 114,845 RSUs received as compensation on 03/01/2026.
  • Prior sale by Spice: 1,365,665 shares ($103.1M) on 01/05/2026.
  • Shares outstanding: 567,445,449; sale represents ~0.01% of total.
  • No undisclosed material adverse info per filer's representation.

Impact Vector

This is a routine sell-to-cover transaction for tax obligations on vesting equity, common among executives and representing a negligible fraction of shares outstanding or Spice's prior activity. It poses no near-term threat to shareholders, as Rocket Lab's operations remain unaffected, and the required representation confirms no hidden adverse developments. Investors should monitor subsequent Form 144s or 4s from Spice or other insiders for any escalation in selling volume that might signal confidence shifts, but this filing aligns with standard compensation practices in the high-growth space sector.

Search
Search across missions, customers, news, and SEC filings